This reasoning makes intuitive sense but misses crucial nuance about how BPC-157 operates at the molecular level
Nat Rev Dis Primers (2018) 4:18001
Studies have not revealed a significant difference, despite claims that some formssuch as sublingual tablets or liquids inserted beneath the tongue to be absorbed through the tissues of the mouthhad better absorption than conventional tablets
Scale that across a BPC-157 and TB-500 stack where you are running both compounds for six weeks, and the waste reaches $30 to $60 easily
However, human clinical evidence is still limited, and larger, well-controlled trials are needed to clarify safety, efficacy, and appropriate use
Electrophysiology results Based on a well-known phenomenon in peripheral nerve injury (i.e., as the number of preserved motoneurons decreases, the MUP (giant potential) in the tail muscle increases), it is conceivable that the BPC 157-treated rats that underwent spinal cord injury and were subjected to EMG recordings exhibited a markedly lower MUP in the tail muscle than that in the corresponding controls (Table 3)
